Literature DB >> 31976830

Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.

Wei Wang1,2, Bin Liu1,2, Xiaoran Duan1, Xiaolei Feng1, Tuanwei Wang1, Pengpeng Wang1, Mingcui Ding1, Qiao Zhang3, Feifei Feng2,3, Yongjun Wu2,3, Wu Yao1, Qi Wang1, Yongli Yang4.   

Abstract

OBJECTIVE: The aim of this study areto screen MicroRNAs (miRNAs) related to the prognosis of lung adenocarcinoma (LUAD) and to explore the possible molecular mechanisms.
METHODS: The data for a total of 535 patients with LUAD data were downloaded from The Cancer Genome Atlas (TCGA) database. The miRNAs for LUAD prognosis were screened by both Cox risk proportional regression model and Last Absolute Shrinkage and Selection Operator (LASSO) regression model. The performances of the models were verified by time-dependent Receiver Operating Characteristic (ROC) curve. The possible biological processes linked to the miRNAs' target genes were analyzed by Gene Ontology (GO), Kyoto gene and genome encyclopedia (KEGG).
RESULTS: Among 127 differentially expressed miRNAs identified from the screening analysis, there are 111 up-regulated and 16 down-regulated miRNAs. Three of them, hsa-miR-1293, hsa-miR-490 and hsa-miR- 5571, were also significantly associated with the survival of the LUAD patients. The targets of the three miRNAs are significantly enriched in systemic lupus erythematosus pathways.
CONCLUSION: Hsa-miR-1293, hsa-miR-490 and hsa-miR-5571 can be potentially used as novel biomarkers for the prognosis prediction of LUAD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Lung adenocarcinoma; TCGA; biomarkers; computational approaches; miRNAs; prognosis.

Mesh:

Substances:

Year:  2020        PMID: 31976830     DOI: 10.2174/1386207323666200124123103

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  2 in total

1.  miR-1293 acts as a tumor promotor in lung adenocarcinoma via targeting phosphoglucomutase 5.

Authors:  Bing Chen; Shiya Zheng; Feng Jiang
Journal:  PeerJ       Date:  2021-09-16       Impact factor: 2.984

2.  Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.

Authors:  Juan Li; Xuyu Gu; Chanchan Gao; Jun Zhang
Journal:  Genet Res (Camb)       Date:  2022-08-27       Impact factor: 1.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.